Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | X027446 | LL |
Vaccine deprived measles; This serious case was reported by a nurse via sales rep and described the occurrence of measles in a 9-month-old female patient who received MMR (Priorix) (batch number X027446, expiry date 27-NOV-2025) for prophylaxis. On 20-FEB-2025, the patient received the 1st dose of Priorix (left thigh). On 23-FEB-2025, 3 days after receiving Priorix, the patient experienced measles (Verbatim: Vaccine deprived measles) (serious criteria other: Other medically imp. condition). On 01-MAR-2025, the outcome of the measles was resolving. The reporter considered the measles to be related to Priorix and Priorix Pre-Filled Syringe Device. The company considered the measles to be unrelated to Priorix and Priorix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-MAR-2025 Nurse reported that patient took 1st dose of Priorix vaccine and experienced vaccine deprived measles.; Sender's Comments: Measles is a listed event which, due to the following criteria (insufficient information provided about the clinical description and laboratory confirmation of disease) is considered unrelated to GSK vaccine Priorix and Priorix Pre-Filled Syringe Device.